MultiCell Technologies Inc (MCET)

[simon wagstaff]

Regarding the CTO

MultiCell Technologies, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on February 28, 2014.
Based on representations by MultiCell Technologies, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.13 through September 27, 2016


Exhibit 10.13 has to do with executive compensation and corporate governance.

Regarding the growing portfolio of patents, MCET still only has one patent directly assigned to them, and it's not the newest patent. If you look carefully at MCET's "patent portfolio" you will see that there is nothing there.

i am certainly willing to admit that MCET could undergo some sort of run orchestrated by the MM, but it will return to previous levels and lower, as you have seen. There is nothing of substance here, just don't believe that there is and get stuck, like many here.

I find it amusing how vigorously posters defend this, it's like a look behind the curtain.